Park Avenue Securities LLC decreased its holdings in Danaher Co. (NYSE:DHR – Free Report) by 9.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 23,253 shares of the conglomerate’s stock after selling 2,298 shares during the quarter. Park Avenue Securities LLC’s holdings in Danaher were worth $6,465,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Stephens Inc. AR lifted its stake in shares of Danaher by 1.0% in the fourth quarter. Stephens Inc. AR now owns 13,601 shares of the conglomerate’s stock valued at $3,147,000 after purchasing an additional 139 shares during the period. Envestnet Asset Management Inc. increased its holdings in Danaher by 5.8% in the fourth quarter. Envestnet Asset Management Inc. now owns 1,019,434 shares of the conglomerate’s stock valued at $235,836,000 after buying an additional 55,458 shares in the last quarter. Morningstar Investment Services LLC lifted its position in shares of Danaher by 82.7% during the 4th quarter. Morningstar Investment Services LLC now owns 2,079 shares of the conglomerate’s stock valued at $485,000 after acquiring an additional 941 shares during the period. Epoch Investment Partners Inc. boosted its position in Danaher by 35.7% during the fourth quarter. Epoch Investment Partners Inc. now owns 176,201 shares of the conglomerate’s stock worth $40,762,000 after purchasing an additional 46,320 shares in the last quarter. Finally, Azimuth Capital Investment Management LLC grew its holdings in Danaher by 29.5% in the fourth quarter. Azimuth Capital Investment Management LLC now owns 1,259 shares of the conglomerate’s stock valued at $291,000 after purchasing an additional 287 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Transactions at Danaher
In other Danaher news, SVP Brian W. Ellis sold 9,600 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total value of $2,641,536.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $5,566,486.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Danaher news, CEO Rainer Blair sold 9,007 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $280.00, for a total transaction of $2,521,960.00. Following the sale, the chief executive officer now owns 97,983 shares in the company, valued at $27,435,240. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Brian W. Ellis sold 9,600 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total value of $2,641,536.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $5,566,486.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 39,659 shares of company stock valued at $11,042,433. 11.10% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on Danaher
Danaher Stock Down 0.2 %
Danaher stock traded down $0.49 during midday trading on Friday, hitting $270.03. 1,132,669 shares of the company were exchanged, compared to its average volume of 2,759,666. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $281.70. The company’s fifty day moving average price is $271.07 and its 200-day moving average price is $258.56. The company has a market cap of $200.01 billion, a PE ratio of 45.77, a price-to-earnings-growth ratio of 4.55 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.15. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period in the previous year, the company posted $2.05 earnings per share. On average, research analysts predict that Danaher Co. will post 7.59 EPS for the current fiscal year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Friday, September 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.40%. Danaher’s dividend payout ratio is presently 18.31%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Roth IRA Calculator: Calculate Your Potential Returns
- MarketBeat Week in Review – 9/30 – 10/4
- How to Capture the Benefits of Dividend Increases
- Top Streaming Companies: Who’s Winning the Battle?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.